GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Inventories, Raw Materials & Components

GRAIL (GRAL) Inventories, Raw Materials & Components : $18.6 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Inventories, Raw Materials & Components?

GRAIL's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $18.6 Mil.

GRAIL's quarterly raw materials declined from Jun. 2024 ($25.5 Mil) to Sep. 2024 ($21.2 Mil) and declined from Sep. 2024 ($21.2 Mil) to Dec. 2024 ($18.6 Mil).

GRAIL's annual raw materials increased from Dec. 2022 ($19.8 Mil) to Dec. 2023 ($21.7 Mil) but then declined from Dec. 2023 ($21.7 Mil) to Dec. 2024 ($18.6 Mil).


GRAIL Inventories, Raw Materials & Components Historical Data

The historical data trend for GRAIL's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Inventories, Raw Materials & Components Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- - 19.76 21.70 18.63

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.70 21.58 25.51 21.21 18.63

GRAIL Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


GRAIL Business Description

Industry
Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.